Reactivity of agalactosyl IgG with rheumatoid factor

Clinica Chimica Acta

Volumn 334, Issue 1-2, 2003, Pages 217-223

  Imafuku, Yuji ^a   Yoshida, Hiroshi ^a   Yamada, Yuji ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Agalactosyl IgG; ELISA; Reactivity; Rheumatoid factor

Indexed keywords

ANTIGEN; EPITOPE; GALACTOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ABSORPTION; ADULT; AGED; ANTIGENICITY; ARTICLE; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 12444297475     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00245-6     Document Type: Article

References (14)

1. Parekh R.B., Dwek R.A., Sutton B.J.et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 316:1985;452-457.
2. Soltys A.J., Hay F.C., Bond A., Axford J.S., Jones M.G., Randen I.et al. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand. J. Immunol. 40:1994;135-143.
3. Tsuchiya N., Endo T., Matsuma K., Yoshinoya S., Aikawa T., Kosuge E.et al. Effects of galactose depletion from oligosaccharide chain on immunological activities of human IgG. J. Rheumatol. 16:1989;285-290.
4. Yamada Y., Hosoda T., Yoshizawa M., Yamane J. Development and evaluation of the lectin-enzyme immunoassay kit for detection of anti-agalactosyl IgG antibodies. Clin. Rep. 31:1997;81-101.
5. Ichikawa Y., Yamada C., Horiki T.et al. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis. Clin. Exp. Rheumatol. 1998;709-715.
6. Nishijima C., Sato S., Takehara K. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. J. Rheumatol. 28:2001;1847-1851.
7. Mizuochi T., Hamako J., Nose M., Titani K. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. J. Immunol. 145:1990;1794-1798.
8. Leader K.A., Lastra G.C., Kirwan J.R., Elson C.J. Agalactosyl IgG in aggregates from the rheumatoid joint. Br. J. Rheumatol. 35:1996;335-341.
9. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S.et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
10. Tan E.M., Cohen A.S., Fries J.F.et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
11. Tomana M., Schrohenloher R.E., Koopman W.J., Alarcon G.S., Paul W.A. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum. 31:1988;333-338.
12. Vaughan J.H. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum. 36:1993;1-6.
13. Van Esch W.J.E., Reparon-Shuijt C.C., Levarht E.W.N., van Kooten C., Breedveld F.C., Verweij C.L. Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells. Clin. Exp. Immunol. 123:2001;496-504.
14. Mannik M. Rheumatoid factor. McCarty D.V. Arthritis and allied condition. 1989;762 Lea & Febiger, Philadelphia.